ProStrakan Group PLC this morning unveiled a potentially lucrative collaboration deal with US biotechnology group Amgen Inc, alongside plans to raise 11.3 mln stg in a share placing to shore up its cash pile.
ProStrakan Group PLC this morning unveiled a potentially lucrative collaboration deal with US biotechnology group Amgen Inc, alongside plans to raise 11.3 mln stg in a share placing to shore up its cash pile.